The 10-second takeaway
For the quarter ended Dec. 31 (Q4), IMAX beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue shrank and GAAP earnings per share dropped significantly.
Gross margins dropped, operating margins expanded, net margins contracted.
IMAX tallied revenue of $66.7 million. The 11 analysts polled by S&P Capital IQ hoped for revenue of $62.9 million on the same basis. GAAP reported sales were 3.6% lower than the prior-year quarter's $69.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.14. The 10 earnings estimates compiled by S&P Capital IQ predicted $0.13 per share on the same basis. GAAP EPS of $0.09 for Q4 were 89% lower than the prior-year quarter's $0.80 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 44.7%, 790 basis points worse than the prior-year quarter. Operating margin was 15.1%, 1,320 basis points better than the prior-year quarter. Net margin was 9.5%, 6,880 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $55.9 million. On the bottom line, the average EPS estimate is $0.12.
Next year's average estimate for revenue is $293.7 million. The average EPS estimate is $1.02.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 1,486 members out of 1,590 rating the stock outperform, and 104 members rating it underperform. Among 449 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 433 give IMAX a green thumbs-up, and 16 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on IMAX is outperform, with an average price target of $25.19.
Over the decades, small-cap stocks, like IMAX have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add IMAX to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of IMAX. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
China's Government Takes Aim at IMAX
IMAX's main rival in China has the company in its crosshairs -- and it has the backing of the Chinese government.
2 Stocks I'd Never Buy, and 1 I'll Consider
All three of these stocks have tumbled more than 20% lower in 2017. Only one of them seems poised to make a comeback.
How IMAX Is Crushing the Rest of the Movie Industry
While most theaters are dealing with declining attendance, audiences are turning to IMAX for a premium experience -- and growth is booming.